0001493152-26-019272.txt : 20260528 0001493152-26-019272.hdr.sgml : 20260528 20260428121202 ACCESSION NUMBER: 0001493152-26-019272 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 245 FIRST STREET RIVERVIEW II 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 444-8400 MAIL ADDRESS: STREET 1: 245 FIRST STREET RIVERVIEW II 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 CORRESP 1 filename1.htm

 

April 28, 2026

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

RE: Enveric Biosciences, Inc.
  Registration Statement on Form S-3
  (File No. 333-295273)
   
  Acceleration Request
  Requested Date: April 29, 2026
  Requested Time: 5:00 p.m., Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Enveric Biosciences, Inc. (the “Company”) requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Commission.

 

Please call Rasika A. Kulkarni of Greenberg Traurig, LLP at (650) 289-7813 to confirm the effectiveness of the Registration Statement or with any questions.

 

  Very truly yours,
   
  Enveric Biosciences, Inc.
     
  By: /s/ Joseph Tucker
  Name: Joseph Tucker, Ph.D.
  Title: Chief Executive Officer